Cargando…
Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?
Diabetic retinopathy (DR) is the leading cause of blindness in working age Americans. Clinicians diagnose DR based on its characteristic vascular pathology, which is evident upon clinical exam. However, extensive research has shown that diabetes causes significant neurovascular dysfunction prior to...
Autores principales: | Shosha, Esraa, Fouda, Abdelrahman Y., Narayanan, S. Priya, Caldwell, R. William, Caldwell, Ruth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073619/ https://www.ncbi.nlm.nih.gov/pubmed/32033258 http://dx.doi.org/10.3390/jcm9020425 |
Ejemplares similares
-
Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
por: Fouda, Abdelrahman Y., et al.
Publicado: (2020) -
Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1
por: Shosha, Esraa, et al.
Publicado: (2018) -
Retinal Neuroprotection From Optic Nerve Trauma by Deletion of Arginase 2
por: Xu, Zhimin, et al.
Publicado: (2018) -
Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair
por: Fouda, Abdelrahman Y., et al.
Publicado: (2022) -
Arginase as a Mediator of Diabetic Retinopathy
por: Patel, Chintan, et al.
Publicado: (2013)